The US is the bigger Anesthesia & Respiratory Devices market: $12.1 Bn against $2.3 Bn in 2023, about 5.2 times as large.
China grows faster: 11% a year, against 7.5%. The gap still grows from $9.7 Bn to $18.3 Bn by 2033.
Clinical research: 110 active trials in the US, 201 in China.
| Measure |  US |  China |
|---|---|---|
| Market size, 2023 | $12.1 Bn | $2.3 Bn |
| Market size, 2033 projected | $24.8 Bn | $6.6 Bn |
| Growth a year (CAGR) | 7.5% | 11% |
| Money added, 2023–2033 | $12.8 Bn | $4.2 Bn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $35 | $1.64 |
| Active clinical trials | 110 | 201 |
| Full report | US report | China report |
Year by year, 2023 to 2033
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Anesthesia & Respiratory Devices, US or China?
The US is the bigger Anesthesia & Respiratory Devices market: $12.1 Bn against $2.3 Bn in 2023, about 5.2 times as large.
Which grows faster in Anesthesia & Respiratory Devices, US or China?
China grows faster: 11% a year, against 7.5%. The gap still grows from $9.7 Bn to $18.3 Bn by 2033.
More Anesthesia & Respiratory Devices comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.